Jonathan Almaden

Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor

Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller et al. · Cancer Cell · 2021 · 172 citations

Tumor Biology, Oncology, Cdk2/4/6 Inhibitor +10

IκBε Is a Key Regulator of B Cell Expansion by Providing Negative Feedback on cRel and RelA in a Stimulus-Specific Manner

Bryce N. Alves, Rachel Tsui, Jonathan Almaden et al. · The Journal of Immunology · 2014 · 64 citations · Full text

A Pathway Switch Directs BAFF Signaling to Distinct NFκB Transcription Factors in Maturing and Proliferating B Cells

Jonathan Almaden, Rachel Tsui, Yi Liu et al. · Cell Reports · 2014 · 49 citations · Full text

B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel

Jonathan Almaden, Yi Liu, Edward Yang et al. · Blood · 2016 · 46 citations · Full text

A multi‐scale approach reveals that NF‐κB <scp>cR</scp> el enforces a B‐cell decision to divide

Maxim N. Shokhirev, Jonathan Almaden, Jeremy Davis‐Turak et al. · Molecular Systems Biology · 2015 · 35 citations · Full text